Andrew Lotery serves as TFS' Medical Scientific Advisor in Ophthalmology since 2020 and he is Professor of Ophthalmology at the University of Southampton.
Professor Lotery trained in Belfast, prior to working for four years at the University of Iowa. He took up his current post as Professor of Ophthalmology at the University of Southampton in 2002.
His clinical specialty is medical retina with major research interests in age-related macular degeneration, central serous chorio-retinopathy and inherited retinal diseases. He has been awarded the Nettleship Award for best research published by a UK ophthalmologist in the past 3 years by the Royal College of Ophthalmologists and was listed in the Times as one of the United Kingdom’s top 100 doctors. He has been recognized for his research by the University Hospital Southampton Innovation and Researcher of the Year awards and a Macular Society award. He was editor in chief of the scientific journal, Eye for 10 years and is currently Chair of the Scientific Committee of the Royal College of Ophthalmologists.
He and his team have performed over 75 clinical trials and published over 240 papers in high impact journals including Nature Genetics, Nature Communications, the Lancet and the New England Journal of Medicine. He has served two times as an NIHR Senior Investigator and raised grant funding totalling over £15 million. He currently leads a Welcome Trust Collaborative Award assessing the role of artificial intelligence in understanding the aetiology of age-related macular degeneration.